43 results
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
a majority of the aggregate issued and outstanding shares of our voting stock.
Under Rule 14c-2(b) of the Exchange Act, none of the actions described … number of shares entitled to vote on the action. Such consent shall have the same force and effect as a majority vote of the stockholders and may
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
the Voting Stockholders who holds a majority of the aggregate issued and outstanding shares of our voting stock.
Under Rule 14c-2(b) of the Exchange Act … of shares entitled to vote on the action. Such consent shall have the same force and effect as a majority vote of the stockholders and may be stated
8-K
EX-4.1
b2ot0ckku
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
8-K
EX-1.1
w3abyovvgos8y0a6
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
8-K
EX-3.1
he46za
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
be5udl1fmzyx 9y
21 Jul 23
Prospectus supplement with pricing info
3:37pm
8-K
0ydjeo fastvd
20 Jul 23
Material Modifications to Rights of Security Holders
11:29am
DEF 14C
pnkczekz ieqjbm2jgf
17 May 23
Information statement
9:07am